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Abstract
 .The effect of the anticancer drug lonidamine LND on the pH of intracellular organelles was studied in isolated rat
 .  .thymocytes by fluorimetric analysis of the bafilomycin-nigericin sensitive uptake of the acridine orange dye AO into
 .acidic compartments. LND brought about a marked reduction )60% in the above pH gradients with a half maximal
decrease at a concentration of 0.25 mM. LND also caused a decrease, although to a lesser extent, in the ATP levels. In
isolated rat liver lysosomes, 0.6 mM LND was found to inhibit ATP-driven organelle acidification by about 80%; minor
inhibition of ATPase activity was observed in the same conditions. In addition, LND was able to promote proton efflux
from isolated lysosomes. On the basis of our results it is suggested that the effect of LND on intracellular proton gradients
 .may be due partially to the decrease in ATP levels, and mostly to a drug-induced increase in the ion proton permeability
of the membranes. q 1997 Elsevier Science B.V.
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1. Introduction
 .Lonidamine LND , a novel antineoplastic agent
belongs to the class of drugs affecting cellular energy
w xmetabolism 1–5 . Based on findings in both cancer
and normal cells, different biochemical functions or
cell structures were proposed as the targets for the
drug action; among these are the mitochondrial-bound
w xhexokinase 2,3 , components of the respiratory chain
w x w x4,5 and cell or organelle membranes 6–8 , for
w x.review 9 . The lactate transport system together
  .Abbreviations: LND, lonidamine 1- 2,4-dichlorobenzyl -1-
.H-indazole-3-carboxylic acid ; AO, acridine orange; MDG, N-
methyl-D-glucamine; pH , cytoplasmic pH; NEM, N-ethylmalei-i
mide
) Corresponding author. Fax: q39 49 8276049.
 .with cytoplasmic pH pH and ATP levels were alsoi
w xrecently shown to be affected by LND 10 .
Using intact rat thymocytes, we found that LND
significantly affected the acidification mechanism that
regulates the lumenal pH of acidic cell organelles.
An analysis of this effect, using also isolated lyso-
somes, suggested that the decrease in the pH gradient
of intracellular organelles might be linked partially to
the decrease in ATP levels, and was due mostly to an
 .increase in the ion most likely proton permeability
of the organelle membrane.
2. Materials and methods
Rat thymocytes were prepared according to stan-
dard procedures, resuspended in a saline containing
0167-4889r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
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135 mM NaCl 5 mM KCl, 5 mM MgSO and 20 mM4
Hepes buffer pH 7.3, and maintained at room temper-
ature. Viability was over 90% during the experiments
 . up to 4 hours . A lysosome-enriched preparation 8-
.to 10-fold was obtained by standard centrifugations
w xof a rat liver homogenate 11 . In some cases the
suspension was further centrifuged in a continuous
w xself-generating Percoll gradient as described 12 ; the
enrichment in lysosomal enzymes in these prepara-
tions was 40- to 60-fold. Protein and enzyme deter-
minations were conducted according to procedures
w xdescribed in 12 . Lysosomal ATPase and proton
w xpumping activities were measured as described 12
with minor modifications. Briefly ATPase was rou-
tinely assayed in quadruplicate by Pi release at 378C,
in the medium described below for the proton pump
assay, containing, in addition, 1 mM EGTA, 200 mM
sodium vanadate, 2 mgrml oligomycin, 1 mgrml
nigericin, 1.3 mM ATP and lysosomes from a puri-
fied preparation at a final concentration of 0.1–0.2
mgrml of protein. Other experimental details are
w xreported in 12 . Proton pumping activity was assayed
 .at room temperature 21"2 in a medium containing
0.12 M KCl, 5 mM MgSO and 20 mM Hepes4
w xbuffer, pH 7.3 adjusted with KOH, as described 12
by following fluorimetrically ATP-driven lysosome
 .uptake of Acridine Orange AO . The dye was ex-
cited at 492 nm and fluorescence emission at 530 nm
was collected, using a Perkin-Elmer MPF 2A spectro-
fluorimeter. A decrease in AO fluorescence under
this conditions indicates an acidification of the or-
ganelles, due to accumulation dependent quenching.
For a more detailed description of the method see
w x  .12 and references therein .
AO uptake by acidic cell organelles was followed
essentially by means of the same procedure, as previ-
w xously described 13 .
The relative ATP content of the cells was deter-
mined by fluorimetric measurement of NADPq re-
w xduction 14 following the addition of an ATP-releas-
 . w xing agent Triton 15 , in the presence of glucose and
appropriate enzyme mixture. In controls, performed
by omitting one of the enzyme, hexokinase, the
amount of endogenous glucose-6-phosphate was
found negligible and this made possible to use rou-
tinely the above mentioned enzyme mixture. The
fluorimetric signal was routinely calibrated by adding
a known amount of ATP at the end of each assay; the
addition of Triton or the presence of oligomycin or
LND, did not interfere with the assay. When glucose
was lacking in the medium, it was added at the
 .proper concentration 5 mM immediately before be-
ginning the assay. The fluorimetric response was
invariably recorded 3 min after ATP liberation by
.Triton . Experiments were carried out at room tem-
perature.
LND was prepared at a concentration of 0.1 M in a
 .0.12 M N-methyl-D-glucamine MDG aqueous solu-
tion. The LND-MDG solution was successively soni-
cated, stored at 48C and used within 2 weeks. At the
maximal final concentration used, neither LND nor
MDG affected AO fluorescence or interfered with
any enzymatic assay. pH changes in the medium
were measured with a glass electrode and a Radiome-
ter PHM 84 pH-meter connected to a Linseis recorder.
All chemical reagents were purchased from Sigma
Chemical Co. LND was kindly supplied by F. An-
 .gelini Institute Rome, Italy .
3. Results
3.1. LND impairment of proton gradients in isolated
thymocytes
Fig. 1 shows the AO uptake by thymocytes in
different experimental conditions. In the absence of
 .additions Fig. 1a , AO uptake, which was complete
in about 20 min, was a result of the pH gradients
across the acidic cell organelles and of the activation
w xof the proton pump 16 restoring the acidic lumenal
 .pH perturbed by the basic dye accumulation . The
uptake of AO, on the other hand, was strongly re-
 .duced in the presence of LND Fig. 1, trace b , which
 .caused an average Fig. 1, plot d 60% dissipation of
the gradient at a concentration of about 0.5 mM and
half maximal dissipation at 0.25 mM. An almost
identical behaviour was observed in a glucose free
 .medium not shown .
We then tried to investigate the mechanism of the
LND-mediated inhibition of AO uptake, a complex
phenomenon which might involve different cellular
processes, such as decrease in ATP levels, inhibition
of the proton pump, and increased proton permeabil-
ity of the organelle membrane. We first analysed the
effect on intracellular proton gradients of various
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q  .Fig. 1. Impairment of intracellular proton gradients by LND or an inhibitor of vacuolar H -ATPase. a–c Uptake of AO by rat
 .  .  .  .thymocytes in the a absence and b presence of LND 0.5 mM and c presence of 0.3 mM bafilomycin. d Dependence of dye uptake
on LND concentration. Data"SD based on 10 distinct experiments. The dye accumulation into acidic vesicles of the cells was assessed
 .  .  .by measuring dye fluorescence decrease see Section 2 . In b and c , cells were incubated with 0.5 mM LND and 0.3 mM bafilomycin
 . A1, respectively, for 20 min before receiving AO 7.5 mM, final concentration as shown. Nigericin addition: 2 mgrml final
.  .  .concentration . The fluorescence scale and bottom time unit refer to all three experiments shown a–c . In the experiments summarised
 .  .in d , cells were incubated with the indicated LND concentration for 10 min before receiving AO 7.5 mM, final concentration ; 25 min
 .  .  .  .later, nigericin final concentration 2–3 mgrml was added and the fluorescence change recorded as shown in a and b . In d , 100%
 . 6corresponds to the fluorescence change indicating dye release recorded in the absence of LND. Cell concentrations, 33=10 rml in
 . 6 .a–c ; 25–37=10 rml in d .
 .  .  .Fig. 2. Time dependence of the effect of: a oligomycin on AO uptake by thymocytes, b and c , oligomycin and LND, respectively, on
 . .ATP levels. a Evaluation of the extent of AO uptake by means of the fluorescence change and other experimental details as in Fig. 1d .
 .  .Data"SD from at least 6 distinct cell preparations. a–c Cells, suspended in the standard glucose medium described in Section 2, were
 .  .incubated with 1.5 mgrml oligomycin c or 0.4 mM LND a,b for the time indicated before initiating the AO or ATP assay. In some
cases glucose was omitted from the medium, as indicated. In the absence of oligomycin or LND addition, corresponding to 100% in the
.  .diagrams no significant variation in AO uptake or ATP levels was observed in either cases "glucose during the entire duration of the
 .  .experiment not more than 4 h . Similarly, oligomycin or LND had no effect in the absence of incubation time zero . Cell concentration
 .  .  . 6 in a , b and c 25–35=10 rml. ATP was measured as described in Section 2, following liberation of cell ATP by Triton final
.concentration 0.2% .
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treatments which impair the cell energy metabolism
of the cells. The internal acidity of organelles of the
vacuolar system is thought to be maintained by an
q w x w x.ATP-driven H pump, 16 , review 17,18 . As
expected, Fig. 2a shows that oligomycin, a well
known inhibitor of the mitochondrial ATP-syn-
thetase, caused a 55% inhibition of AO uptake in the
presence of glucose and a 85% in the absence follow-
ing a 3–4 h incubation. Furthermore, bafilomycin
A1, a specific inhibitor of vacuolar Hq-ATPase in
w xisolated organelles 19 , completely inhibited AO up-
 .take at a concentration of 0.3 mM Fig. 1, trace c ;
this finding strengthens the hypothesis that AO up-
take is driven by the proton gradient across the
membrane of acidic organelles.
As expected, oligomycin not only reduced AO
uptake, but it also affected ATP levels in a similar
 .manner Fig. 2b ; bafilomycin A1, on the other hand,
 .did not modify ATP levels not shown . LND caused
 .a decrease in ATP levels Fig. 2c , which, unlike for
oligomycin, was not significantly different in the
presence and in the absence of glucose; most of the
decrease occurred after 30 minutes incubation. Fur-
thermore, the LND-induced reduction in ATP levels
was less than that required on the grounds of the
.findings with oligomycin, see Fig. 2 to induce the
decrease in the pH gradients elicited by LND. This
suggested that, in addition to ATP levels, other fac-
tors could be involved in the LND impairment of
proton gradients.
3.2. LND effects on ATP dri˝en acidification, ATPase
acti˝ity and proton permeability in isolated lyso-
somes
A striking inhibition of the Hq-pump was induced
by LND in isolated rat liver lysosomes compare
.traces a and b of Fig. 3 , which was almost complete
 . 80%, on the average at 0.6 mM drug Fig. 3, plot
.d . Trace c also shows that 50 nM bafilomycin A1
completely inhibited ATP–driven AO uptake. To test
whether the LND effect might be due to a drug-in-
duced proton permeability that would also result in
an apparent inhibition of the proton translocating
mechanism, we took advantage of the finding that the
pH gradient is, at least in part, conserved for some
time in freshly prepared, lysosome-enriched suspen-
 q .sions, maintained in a K -free sucrose medium
w x  .11 . As shown in Fig. 4 trace a and b , where higher
lysosome concentrations were used compared to Fig.
 .Fig. 3. LND or bafilomycin A1 inhibition of ATP-driven lysosome acidification. In a–c , lysosome-enriched preparations were used. The
 . .low AO uptake before ATP addition is due to a resistant small pH gradient in these preparations. In b LND 0.4 mM was present. In d
 .the extent of ATP-induced AO fluorescence change percent of the value recorded in the absence of the drug is shown as a function of
 .  . LND concentration. In b and d the drug was added 10 min about before AO data"SD from 7 different lysosomes preparations
.  .including purified lysosomes . In a–c final concentrations of AO, ATP and nigericin were 5 mM, 1 mM and 1 mgrml, respectively.
 .  .  .The time scale indicated at the bottom refers to all a–c . In c , bafilomycin A1 was added 50 nM, final concentration a few minutes
 .  .before AO. The protein concentration of the lysosomal suspension was 0.3 mgrml in a–c , and 0.2–0.4 and 0.05–0.1 mgrml in d
when enriched and purified lysosome preparations, respectively, were used. Since no significant difference in the inhibition curve was
 .observed the dye responds only to organelles able to acidify their interior when enriched and purified lysosome preparations were used,
 .data from two preparations could be used together to construct the curve shown in d .
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 .Fig. 4. a,b Dissipation of the lysosomal pH gradient by nigericin
 .or LND; c,d medium acidification following addition of
 .nigericin or LND. An aliquot 50–100 ml of a lysosome-en-
riched suspension in a sucrose medium was added to 2 ml of a
KCl medium immediately before AO uptake or pH determina-
 .tion, respectively. AO concentration in a,b 5 mM. Nigericin and
 .LND addition final concentrations : 1 mgrml and 0.5 mM in
 .  .  .  .a,b respectively, the double in c,d . HCl addition in c and d ,
2 ml from a 0.1 M HCl solution. Medium buffer concentration:
 .  .  .  .20 mM in a and b ; 6 mM in c and d . Protein concentration
 .  .  .  .was in a and b s0.7 mgrml in c and d s1.4 mgrml. The
experiments shown were repeated at least three times using
different preparations, and similar results were obtained.
3, the pH gradient was unmasked by the AO uptake
which could be recorded in the absence of ATP. Due
to the high Kq medium used in these assays, the
w xgradient was obviously destroyed by nigericin 11 . A
similar albeit slower effect was observed following
LND addition. In the absence of additions Fig. 4,
.trace b , there was a time dependent loss of pH
gradient which, however, was significantly slower
 .about 1r3, when comparing initial rates than that
elicited by LND. The proton efflux inferred by the
above results was directly measured as a pH decrease
in the external medium in a poorly buffered medium
 .Fig. 4, trace c and d .
 .In both cases nigericin or LND addition , the time
courses of AO fluorescence and of pH changes in the
medium were very similar, as shown in the same
figure.
Finally, we analysed the effect of LND on ATPase
activity in purified lysosomes. To prevent the mask-
ing of ATPase inhibition by the LND-induced in-
crease in proton permeability, which is thought to
w xstimulate ATPase activity 12 , the assays were per-
formed in the presence of nigericin. Some LND
  .inhibition was observed 24% with SD 8% ns6 ,
.data not shown ; however, when the measurements
were repeated in the presence of NEM or bafilomycin,
ATPase inhibition by LND was stronger and the
increase was comparable to that of LND alone. Thus,
the significance of these data remained unclear, as
discussed below.
4. Discussion
In confronting the problem of an anticancer drug’s
mechanism of action it is evidently important to
study its effect on normal cells.
Many cellular activities or structures have been
w xproposed as the targets of LND action 1–8 . Re-
cently, lactate, ATP levels and pH were measured ini
LND-treated cultured human breast cancer cells by
means of 31P-NMR; lactate was found to accumulate
inside the cells, while ATP levels and pH were bothi
decreased; LND did not inhibit hexokinase activity
 13 .assayed by means of C-NMR , thus suggesting that
w xglycolysis was poorly affected by LND 10 . How-
ever, in contrast with these data, the inhibition of
hexokinase by LND in cultured human cancer cells
w xhas also been recently reported 20 . This discrepancy
might arise from the different experimental condi-
 w xtions intact cells in ref. 10 , versus lysed cells in
w x.20 . We also observed a reduction in the levels of
ATP following drug addition. Moreover, at concen-
trations not much higher than those tested in other
studies, we observed a significant decrease in the
acidity of the intracellular organelles.
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The comparison of the effects of LND on the
acidity of the intracellular organelles and on the
levels of ATP suggests that the drop in pH gradients
could be partially explained by the decrease in the
ATP levels; however, the LND-induced Hq-pump
impairment, that we could observe in isolated or-
ganelles, needs to be taken into account. Our results
 .suggest two hypothesis for this effect: i an in-
q  q q.creased H or H -K conductance of the or-
ganelles membranes; this is shown in our study by
two independent findings, i.e., LND induced both AO
q  .and H efflux from lysosomes; ii an impairment of
the enzymatic activity that drives proton pumping.
However, the interpretation of results concerning AT-
Pase activity is not straightforward. In fact, the
LND-inhibitable ATPase fraction did not completely
 .overlap with the NEM or bafilomycin -sensitive AT-
Pase. On the other NEM-sensitive ATPase is only a
w xfraction of the overall ATPase activity 12 , and
w x.references therein, 21 and even in highly purified
lysosomal preparations, minor contamination by other
w xsubcellular fractions cannot be ruled out 12 . The
inhibition provided by LND could not thus be linked
to proton pumping but involve other ATPase activi-
ties and further investigation is needed.
 .The rapid drop 20 min of incubation in the pH
gradient observed following the addition of the vac-
q uolar H -ATPase inhibitor, bafilomycin A1 Fig. 1,
.trace c , might in part reflect a modification in lume-
nal pH due to AO uptake into acidic compartments;
however, this finding seems also to indicate that a
continuous enzyme activity is required to maintain
the pH gradients, probably to overcome a proton
leakage from the organelles or equivalent transport
.process also resulting in internal pH increase , as
 .suggested also by the data of Fig. 4 trace b . Al-
though we observed this proton flux in isolated or-
ganelles when proton discharge was caused by
nigericin or LND, whether it is sufficient to elicit the
LND-induced decrease in pH observed by othersi
w x10 , is a moot point.
Our finding of a decrease in ATP levels is in line
with the current notion that LND affects the energy
production mechanism; however, in our case see
w x.also 10 , it cannot be explained by an inhibition of
the glycolytic pathway alone, because ATP depletion
by the drug was observed also in the absence of
 .glucose Fig. 2c , and glucose shortage has no or
very little effect on the ATP levels for some hours in
w xthese and other normal cells 15,22 . Similarly, the
effect of LND on the intracellular proton gradient
was observed also in the absence of glucose, thus
suggesting that it could not be linked to glycolysis
inhibition. Therefore, it is possible that an impair-
ment in respiration linked energy production is in-
volved, and, although indirectly, our findings see
w x.also 5 suggest the increase in proton permeability
as a drug effect that could impair the energy-produc-
ing apparatus of the mitochondria. In contrast with
wthis suggestion for a more complete discussion see
w x.5 , early studies on the LND effect indicated that it
inhibited respiration as well as lactate production in
w xintact cells 23 . However, it was recently reported
that in isolated myocytes, under conditions in which
cytochrome oxidase turns over at its maximal rate,
the rate of oxygen consumption was increased when
w xthe cells were obtained from LND treated rats 5 and
w xin an another recent study 20 the percent of coupled
respiration was found to decrease after exposure of
human cancer cells to LND.
Finally, it should be noticed that LND effects were
not superimposible to those of oligomycin. Thus, an
another possibility that should be considered is that
LND induces energy overconsumption due possibly
.to proton cycling more than impairing energy pro-
ducing processes.
In conclusion, the present study confirms that the
action mechanism of the antineoplastic agent LND
may involve multiple effects, among which a de-
crease in the acidity of organelles of the vacuolar
system, partially linked to a decrease in ATP levels,
but, in our view, mostly to an increased membrane
 .ion most likely proton permeability. It must be
observed that the drug concentrations necessary to
induce maximal effects in our study are higher about
.  w x.double than in others see, e.g. 20 . However pre-
liminary findings in Ehrlich ascites tumor cells paper
.in preparation show similar effect at concentrations
2–3 times lower. Thus, the possibility that LND
utilises the above or other correlated events to exert
its damaging effect on cancer cells, by possibly tak-
ing advantage of their physico-chemical or biochemi-
 w xcal features such as different pH 24 and energyi
w xmetabolism 25 and lower capacity to maintain nor-
mal ATP levels in the face of energy substrate short-
w x.age 15,22,26 , would deserve further investigations.
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